Egyszerű nézet

dc.contributor.author Franke B
dc.contributor.author Michelini G
dc.contributor.author Asherson P
dc.contributor.author Banaschewski T
dc.contributor.author Bilbow A
dc.contributor.author Buitelaar JK
dc.contributor.author Cormand B
dc.contributor.author Faraone SV
dc.contributor.author Ginsberg Y
dc.contributor.author Haavik J
dc.contributor.author Kuntsi J
dc.contributor.author Larsson H
dc.contributor.author Lesch KP
dc.contributor.author Ramos-Quiroga JA
dc.contributor.author Réthelyi, János
dc.contributor.author Ribases M
dc.contributor.author Reif A
dc.date.accessioned 2019-07-05T08:01:17Z
dc.date.available 2019-07-05T08:01:17Z
dc.date.issued 2018
dc.identifier journalVolume=28;journalIssueNumber=10;journalTitle=EUROPEAN NEUROPSYCHOPHARMACOLOGY;pagerange=1059-1059;journalAbbreviatedTitle=EUR NEUROPSYCHOPHARM;
dc.identifier.citation pagination=1059-1088; journalVolume=28; journalIssueNumber=10; journalTitle=EUROPEAN NEUROPSYCHOPHARMACOLOGY;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/6622
dc.identifier.uri doi:10.1016/j.euroneuro.2018.08.001
dc.description.abstract Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
dc.format.extent 1059-1088
dc.relation.ispartof urn:issn:0924-977X 1873-7862
dc.title Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan
dc.type Journal Article
dc.date.updated 2019-01-03T09:25:01Z
dc.rights.holder NULL
dc.identifier.mtmt 3418288
dc.identifier.pubmed 30195575
dc.contributor.department SE/AOK/K/Pszichiátriai és Pszichoterápiás Klinika
dc.contributor.department SE/AOK/K/PPK/MTA-SE-NAP B Molekuláris pszichiátriai és in vitro betegségmodellezési kutatócsoport
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet